For Atomo Diagnostics, the market turmoil has been no reason to delay its initial public offering plans. Shares in the Australian medical device manufacturer doubled on their debut today. The…
For Atomo Diagnostics, the market turmoil has been no reason to delay its initial public offering plans. Shares in the Australian medical device manufacturer doubled on their debut today. The…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


